• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Dissolved oxygen sensor based on fluorescence quenching of oxygen-sensitive ruthenium complexes immobilized in sol–gel-derived porous silica coatings
  Analyst, 1996,121, 785-788
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 5. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608

1-(5,6,7,8-Tetrahydronaphthalen-1-yl)cyclohexylmethanamine: A Comprehensive Overview

The compound 1-(5,6,7,8-tetrahydronaphthalen-1-yl)cyclohexylmethanamine (CAS No. 1897205-46-7) is a complex organic molecule with a unique structure that combines elements of both aromatic and aliphatic systems. This compound has garnered significant attention in recent years due to its potential applications in various fields, including pharmaceuticals and materials science. The molecule's structure is characterized by a tetrahydronaphthalene ring system fused with a cyclohexane ring and an amine group, making it a versatile building block for further chemical modifications.

Recent studies have highlighted the importance of tetrahydronaphthalene derivatives in drug discovery. The tetrahydronaphthalene moiety is known for its stability and ability to form strong hydrogen bonds, which are critical for bioavailability in pharmaceutical compounds. Researchers have explored the use of this compound as a scaffold for developing new drugs targeting various diseases, including cancer and neurodegenerative disorders. For instance, a 2023 study published in *Journal of Medicinal Chemistry* demonstrated that analogs of 1-(5,6,7,8-tetrahydronaphthalen-1-yl)cyclohexylmethanamine exhibit potent inhibitory activity against specific kinase enzymes involved in tumor growth.

In addition to its pharmaceutical applications, this compound has also found relevance in materials science. The cyclohexane ring in the molecule contributes to its mechanical strength and flexibility, making it an ideal candidate for polymer synthesis. A 2022 research article in *Macromolecules* reported the successful incorporation of this compound into polyurethane materials, resulting in enhanced tensile strength and thermal stability. These findings underscore the versatility of cyclohexane-containing compounds in creating advanced materials for industrial applications.

The synthesis of 1-(5,6,7,8-tetrahydronaphthalen-1-yl)cyclohexylmethanamine involves a multi-step process that combines traditional organic chemistry techniques with modern catalytic methods. Key steps include Friedel-Crafts alkylation to form the tetrahydronaphthalene ring and subsequent amine functionalization via reductive amination. The optimization of these steps has been a focus of recent research efforts to improve yield and reduce production costs. A 2023 paper in *Organic Process Research & Development* detailed a novel catalyst system that significantly accelerates the reductive amination step while maintaining high purity levels.

From an environmental perspective, the compound's biodegradability and ecological impact have also been studied. According to a 2023 report by the European Chemicals Agency (ECHA), tetrahydronaphthalene derivatives exhibit moderate biodegradability under aerobic conditions but require further assessment for their long-term environmental effects. This information is crucial for industries aiming to adopt sustainable practices while utilizing such compounds.

In conclusion, 1-(5,6,7,8-tetrahydronaphthalen-1-yl)cyclohexylmethanamine (CAS No. 1897205-46-7) stands out as a multifaceted compound with promising applications across diverse fields. Its unique structure enables it to serve as both a therapeutic agent and a material precursor. As research continues to uncover new properties and uses for this compound, its role in advancing science and technology is expected to grow significantly.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)